METTLER TOLEDO INTERNATIONAL INC/ is 6.2x more valuable than 10x Genomics, Inc. by market capitalization ($22.90 B vs $3.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TXG | MTD |
|---|---|---|
| Market cap | $3.72 B | $22.90 B |
| US-listed rank | #1634 | #562 |
| Revenue (latest FY) | $642.82M | $4.03B |
| Net income (latest FY) | -$43.50M | $869.19M |
| Net margin | -6.8% | 21.6% |
| P/E (trailing FY) | - | 26.3 |
| SEC filings | 652 | 1,692 |
METTLER TOLEDO INTERNATIONAL INC/ is 6.2x more valuable than 10x Genomics, Inc. by market capitalization ($22.90 B vs $3.72 B).
In their latest fiscal years, 10x Genomics, Inc. reported $642.82M in revenue while METTLER TOLEDO INTERNATIONAL INC/ reported $4.03B.
Full pages: 10x Genomics, Inc. and METTLER TOLEDO INTERNATIONAL INC/, or browse the full rankings.